If you work in a school and are a principal, teacher, nurse, school board member, district superintendent or anyone else who interacts with a child who is being treated for cancer, this section is for you. Because cancer in children […]
Guidance for School Personnel Read More »
When a school-aged child is diagnosed with cancer, it is important to keep the child connected to school and friends. These connections send an important message: your cancer will be cured; you need school for your future; and you will
Our hope is that in the future kids not only have a great chance of surviving, but LIVING without the terrible side effects today’s childhood cancer treatments cause. Donate to Violet’s Fund for Childhood Cancer Research Violet’s Story Diagnosis and
Today, we’re announcing $2M in funding for a new pediatric brain cancer clinical trial. Dr. Mohamed Abdelbaki’s team is testing a new type of cancer immunotherapy in children with recurrent brain tumors, with funding from a CureSearch Catapult Award. August
Mohamed Shebl Abdelbaki, MD Washington University School of Medicine in St. Louis Catapult Award: 2024-2027 Focus: Recurrent Brain Tumors; Natural Killer (NK) Cell Therapy Project title: Phase I Study of Natural Killer Cells in Recurrent Malignant Brain Tumors About Dr. Abdelbaki
Mohamed S. Abdelbaki, MD Read More »
JOIN US FOR 2024 PEDS A VIRTUAL CONFERENCE | OCT. 9-10, 2024 Reality Check: Entrepreneurship and Regulatory Navigation in Pediatric Cancer Drug Development REGISTRATION – NOW CLOSED Thank you, attendees! Stay tuned for details about 2025 PEDS. Presented by Uniting
CureSearch Pediatric Early Development Symposium Read More »
We’re partnering internationally to create far-reaching impact for kids with cancer We’re excited to share news of our recent partnership with LifeArc, a highly-regarded UK-based medical research charity. LifeArc will co-fund Dr. Gregory Friedman’s CureSearch Acceleration Initiative (AI) project aimed
CureSearch and UK-based LifeArc to Co-fund Nearly $1.5M in High-grade Glioma Research Read More »
The prognosis for metastatic Ewing sarcoma can be devastating. Dr. Lee’s research may change that. Ewing sarcoma (ES) is a bone cancer that can be difficult to treat once it has spread. The 5-year survival rate for children with the
Dr. Lee’s Mission: A Promising Future for Children with Advanced Ewing Sarcoma Read More »
JOHN LEE, MD, PhD David Geffen School of Medicine at UCLA CureSearch Acceleration Initiative Award: 2023-2025 Focus: Ewing sarcoma Project title: IL-18 armored STEAP1 CAR T cell therapy for Ewing sarcoma “Metastatic Ewing sarcoma is rarely curable and current treatments like surgery,
In partnership with CureSearch, we’ve launched “Garret & I: The Garret Collins Legacy Fund” in honor of our incredible son. Donate to Garret’s Fund With your support, we’re funding important research for new cures. John Lee, MD, PhD | David
Garret & I: The Garret Collins Legacy Fund Read More »
